Skip to main content
SpringerLink
Log in

Radiothérapie des métastases osseuses : indications actuelles et nouvelles perspectives

Radiotherapy for bones metastases: Current indications and new perspectives

  • Mise au Point / Update
  • Published:
Oncologie

Résumé

La radiothérapie antalgique des métastases osseuses de première intention est un traitement efficace quel que soit le fractionnement (traitement mono- ou plurifractionné). La radiothérapie peut également être proposée en cas d’échec ou d’efficacité insuffisante d’une première irradiation (après avoir éliminé une fracture) ou l’apparition de nouveaux sites douloureux. Les autres indications sont les compressions médullaires en adjuvant à la chirurgie ou de façon exclusive et les irradiations après chirurgie pour métastase des os longs. Le développement de la radiothérapie de haute précision (en conditions stéréotaxiques) augmente les possibilités de réirradiation lorsque les doses maximales admissibles par les tissus sains ont été atteintes. Elle cherche à améliorer le contrôle local, voire la survie, chez les patients oligométastatiques.

Abstract

First-line palliative radiotherapy for painful bone metastases is an effective treatment whatever its fractionation (single or multiple fractions). It is also advisable after failure or insufficient effect of a first irradiation, or the appearance of new painful site. Other indications are spinal cord compression, either as an adjuvant to surgery or as sole treatment, and after surgery for long-bone metastases. The development of high-precision techniques (stereotactic conditions) enlarges the possibility of re-irradiation while tolerance doses to normal tissues have already been delivered. Local control and possibly overall survival could be improved in oligometastatic patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Références

  1. Leddy ET (1930) The roentgen treatment of metastasis to the vertebrae and the bones of the pelvis from carcinoma of the breast. Am J Roentgenol 24: 657–72

    Google Scholar 

  2. Hoskin PJ, Stratford MR, Folkes LK, et al (2000) Effect of local radiotherapy for bone pain on urinary markers of osteoclast activity. Lancet 355: 1428–9

    Article  CAS  PubMed  Google Scholar 

  3. Chow E, Hoskin P, Mitera G, et al. (2012) Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Int J Radiat Oncol Biol Phys 82: 1730–7

    Article  PubMed  Google Scholar 

  4. Chow E, Wu JS, Hoskin P, et al. (2002) International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiother Oncol 64: 275–80

    Article  PubMed  Google Scholar 

  5. McQuay HJ, Carroll D, Moore RA (1997) Radiotherapy for painful bone metastases: a systematic review. Clin Oncol (R Coll Radiol) 9: 150–4

    Article  CAS  Google Scholar 

  6. Wu JS, Wong R, Johnston M, et al. (2003) Meta-analysis of dosefractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys 55: 594–605

    Article  PubMed  Google Scholar 

  7. Sze WM, Shelley M, Held I, Mason M (2004) Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy — a systematic review of the randomised trials. Cochrane Database Syst Rev (2):CD004721

    PubMed  Google Scholar 

  8. Chow E, Harris K, Fan G, et al. (2007) Palliative radiotherapy trials for bone metastases: a systematic review. J Clin Oncol 25: 1423–36

    Article  PubMed  Google Scholar 

  9. Blitzer PH (1985) Reanalysis of the RTOG study of the palliation of symptomatic osseous metastasis. Cancer 55: 1468–72

    Article  CAS  PubMed  Google Scholar 

  10. Tong D, Gillick L, Hendrickson FR (1982) The palliation of symptomatic osseous metastases: final results of the Study by the Radiation Therapy Oncology Group. Cancer 50: 893–9

    Article  CAS  PubMed  Google Scholar 

  11. Hartsell WF, Scott CB, Bruner DW, et al. (2005) Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst 97: 798–804

    Article  PubMed  Google Scholar 

  12. Roos DE, Turner SL, O’Brien PC, et al. (2005) Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05). Radiother Oncol 75: 54–63

    Article  PubMed  Google Scholar 

  13. Jeremic B, Shibamoto Y, Acimovic L, et al. (1998) A randomized trial of three single-dose radiation therapy regimens in the treatment of metastatic bone pain. Int J Radiat Oncol Biol Phys 42: 161–7

    Article  CAS  PubMed  Google Scholar 

  14. Hoskin PJ, Price P, Easton D, et al. (1992) A prospective randomised trial of 4 Gy or 8 Gy single doses in the treatment of metastatic bone pain. Radiother Oncol 23: 74–8

    Article  CAS  PubMed  Google Scholar 

  15. Chow E, van der Linden YM, Roos D, et al. (2014) Single versus multiple fractions of repeat radiation for painful bone metastases: a randomised, controlled, non-inferiority trial. Lancet Oncol 15: 164–71

    Article  PubMed  Google Scholar 

  16. Steenland E, Leer JW, van Houwelingen H, et al. (1999) The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. Radiother Oncol 52: 101–9

    Article  CAS  PubMed  Google Scholar 

  17. van der Linden YM, Lok JJ, Steenland E, et al. (2004) Single fraction radiotherapy is efficacious: a further analysis of the Dutch Bone Metastasis Study controlling for the influence of retreatment. Int J Radiat Oncol Biol Phys 59: 528–37

    Article  PubMed  Google Scholar 

  18. Jeremic B, Shibamoto Y, Igrutinovic I (1999) Single 4 Gy reirradiation for painful bone metastasis following single fraction radiotherapy. Radiother Oncol 52: 123–7

    Article  CAS  PubMed  Google Scholar 

  19. Chow E, Meyer RM, Chen BE, et al. (2014) Impact of reirradiation of painful osseous metastases on quality of life and function: a secondary analysis of the NCIC CTG SC.20 randomized trial. J Clin Oncol 32: 3867–73. doi: 10.1200/JCO.2014.57.6264. Epub 2014 Oct 27

    Article  PubMed  Google Scholar 

  20. Kirkpatrick JP, van der Kogel AJ, Schultheiss TE (2010) Radiation dose-volume effects in the spinal cord. Int J Radiat Oncol Biol Phys 76: S42–S9

    Article  PubMed  Google Scholar 

  21. Maranzano E, Bellavita R, Rossi R, et al. (2005) Short-course versus split-course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. J Clin Oncol 23: 3358–65

    Article  PubMed  Google Scholar 

  22. Maranzano E, Trippa F, Casale M, et al. (2009) 8 Gy single-dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiother Oncol 93: 174–9

    Article  PubMed  Google Scholar 

  23. Rades D, Abrahm JL (2010) The role of radiotherapy for metastatic epidural spinal cord compression. Nat Rev Clin Oncol 7: 590–8

    Article  PubMed  Google Scholar 

  24. Rades D, Hoskin PJ, Stalpers LJ, et al. (2006) Short-course radiotherapy is not optimal for spinal cord compression due to myeloma. Int J Radiat Oncol Biol Phys 64: 1452–7

    Article  PubMed  Google Scholar 

  25. Rades D, Fehlauer F, Schulte R, et al. (2006) Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression. J Clin Oncol 24: 3388–93

    Article  PubMed  Google Scholar 

  26. Hird A, Chow E, Zhang L, et al. (2009) Determining the incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: results from three canadian cancer centers. Int J Radiat Oncol Biol Phys 75: 193–7

    Article  PubMed  Google Scholar 

  27. Hird A, Zhang L, Holt T, et al. (2009) Dexamethasone for the prophylaxis of radiation-induced pain flare after palliative radiotherapy for symptomatic bone metastases: a phase II study. Clin Oncol (R Coll Radiol) 21: 329–35

    Article  CAS  Google Scholar 

  28. Koswig S, Budach V (1999) Remineralization and pain relief in bone metastases after different radiotherapy fractions (10 times 3 Gy vs 1 time 8 Gy). A prospective study. Strahlenther Onkol 175: 500–8

    Article  CAS  PubMed  Google Scholar 

  29. Weber W, Rosler HP, Doll G, et al. (1992) The percutaneous irradiation of osteolytic bone metastases — a course assessment. Strahlenther Onkol 168: 275–80

    CAS  PubMed  Google Scholar 

  30. Koswig S, Buchali A, Bohmer D, et al. (1999) Palliative radiotherapy of bone metastases. A retrospective analysis of 176 patients. Strahlenther Onkol 175: 509–14

    Article  CAS  PubMed  Google Scholar 

  31. Timmerman RD, Kavanagh BD, Cho LC, et al. (2007) Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol 25: 947–52

    Article  PubMed  Google Scholar 

  32. Gerszten PC, Burton SA, Ozhasoglu C, Welch WC (2007) Radiosurgery for spinal metastases: clinical experience in 500 cases from a single institution. Spine (Phila Pa 1976) 32: 193–9

    Article  Google Scholar 

  33. Pichon B, Thillays F, Bourgier C, et al. (2014) Hypofractionated stereotactic radiotherapy of bone metastases. Cancer Radiother 18: 342–9

    Article  CAS  PubMed  Google Scholar 

  34. Moulding HD, Elder JB, Lis E, et al. (2010) Local disease control after decompressive surgery and adjuvant high-dose single-fraction radiosurgery for spine metastases. J Neurosurg Spine 13: 87–93

    Article  PubMed  Google Scholar 

  35. Thariat J, Fric D, Kerr C, et al. (2013) Advances in radiation oncology for metastatic bone disease. Bull Cancer 100: 1187–97

    PubMed  Google Scholar 

  36. Lutz S, Berk L, Chang E, et al. (2011) Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys 79: 965–76

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Quantif-Litis EA 4108, département de radiothérapie et de physique médicale, centre Henri-Becquerel, F-76038, Rouen, France

    S. Thureau, C. Hanzen & B. Dubray

  2. Groupe européen d’étude des métastases osseuses (GEMO), Paris, France

    S. Thureau & J. L. Lagrange

  3. Service de radiothérapie, hôpital Henri-Mondor, UPEC, 51, avenue du Mal-de-Lattre-de-Tassigny, F-94010, Créteil, France

    J. L. Lagrange

Authors
  1. S. Thureau
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Hanzen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. Dubray
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. L. Lagrange
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Thureau.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Thureau, S., Hanzen, C., Dubray, B. et al. Radiothérapie des métastases osseuses : indications actuelles et nouvelles perspectives. Oncologie 17, 91–95 (2015). https://doi.org/10.1007/s10269-015-2492-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10269-015-2492-5

Mots clés

Keywords

Search

Navigation